ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Thoracic

August 27, 2022
Most surgeons practice in high income countries, even though the majority of the world’s population lives in low- or middle-income countries. There is a significant disparity between high-income and low-income countries in the number of both cardiac and pediatric cardiac surgeons.
August 24, 2022
This is a presentation about a new understanding of thoracic outlet syndrome and the role of robotic first rib resection in the treatment of this disease.
August 23, 2022
Professor Nasser Altorki joins Mara Antonoff and Joel Dunning to discuss the breakthrough results of the CALGB 140503 surgery trial.
August 19, 2022
Surgical management for potentially resectable stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial.
August 15, 2022
Watch the discussion between Dr. Alan Sihoe and his esteemed colleagues as they talk about the Guest Editor Series topic, "Segmentectomy for Lung Cancer."
August 12, 2022
Investigators in the CALGB 140503 recently presented the results of phase 3 of the trial at the IACSLC World Conference on Lung Cancer 2022 in Vienna.
August 11, 2022
This video displays a uniportal robotic left upper lobe sleeve resection performed by Diego Gonzalez Rivas.
August 10, 2022
This video presents a surgical technique to perform a video-assisted "hilum first-fissure last" right lower lobectomy with two-port approach.
August 5, 2022
The topic of symptoms and conditions that result from prior COVID-19 infection over four weeks after infection is a great topic of concern. New research from the U.S. Center for Disease Control & Prevention (CDC) aims to further assess potential risks for select children and adolescents.
August 5, 2022
The segmentectomy procedure is emerging as the preferred resection treatment for select patients with stage IA NSCLC < 2cm. This preference is supported by a mountain of retrospective data and the survival advantage noted in the recently reported JCOG 0802 trial.

Pages